Mizuho Securities Downgrades Sucampo Pharmaceuticals (SCMP) to Neutral

August 4, 2016 6:24 AM

Mizuho Securities downgraded Sucampo Pharmaceuticals (NASDAQ: SCMP) from Buy to Neutral with a price target of $13.00.Analyst Irina Koffler commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found